161 related articles for article (PubMed ID: 36266327)
1. Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia.
Kubota Y; Zawit M; Durrani J; Shen W; Bahaj W; Kewan T; Ponvilawan B; Mori M; Meggendorfer M; Gurnari C; LaFramboise T; Feurstein S; Sekeres MA; Visconte V; Godley LA; Haferlach T; Maciejewski JP
Leukemia; 2022 Dec; 36(12):2827-2834. PubMed ID: 36266327
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous
Marsh JCW; Gutierrez-Rodrigues F; Cooper J; Jiang J; Gandhi S; Kajigaya S; Feng X; Ibanez MDPF; Donaires FS; Lopes da Silva JP; Li Z; Das S; Ibanez M; Smith AE; Lea N; Best S; Ireland R; Kulasekararaj AG; McLornan DP; Pagliuca A; Callebaut I; Young NS; Calado RT; Townsley DM; Mufti GJ
Blood Adv; 2018 Jan; 2(1):36-48. PubMed ID: 29344583
[TBL] [Abstract][Full Text] [Related]
3. An acquired BMF with FANCL gene heterozygous mutation: Case report.
Zhang N; Wang X; Miao XJ; Zhang XP; Xia XY; Li L; Sun HP
Medicine (Baltimore); 2023 Jun; 102(24):e34036. PubMed ID: 37327301
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of a Protocolized In-Depth Evaluation of Pediatric Bone Marrow Failure: A Multi-Center Prospective Cohort Study.
Atmar K; Ruivenkamp CAL; Hooimeijer L; Nibbeling EAR; Eckhardt CL; Huisman EJ; Lankester AC; Bartels M; Santen GWE; Smiers FJ; van der Burg M; Mohseny AB
Front Immunol; 2022; 13():883826. PubMed ID: 35572556
[TBL] [Abstract][Full Text] [Related]
5. The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
Hakkarainen M; Kaaja I; Douglas SPM; Vulliamy T; Dokal I; Soulier J; Larcher L; Peffault de Latour R; Leblanc T; Sicre de Fontbrune F; Siitonen T; Lohi O; Hellström-Lindberg E; Barbany G; Tesi B; Shimamura A; Beier F; Jackson S; Kuperman AA; Falik Zaccai T; Tamary H; Mecucci C; Capolsini I; Jahnukainen K; Salmenniemi U; Niinimäki R; Varilo T; Kilpivaara O; Wartiovaara-Kautto U
Blood; 2023 Jun; 141(23):2853-2866. PubMed ID: 36952636
[TBL] [Abstract][Full Text] [Related]
6. Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
Blombery P; Fox L; Ryland GL; Thompson ER; Lickiss J; McBean M; Yerneni S; Hughes D; Greenway A; Mechinaud F; Wood EM; Lieschke GJ; Szer J; Barbaro P; Roy J; Wight J; Lynch E; Martyn M; Gaff C; Ritchie D
Haematologica; 2021 Jan; 106(1):64-73. PubMed ID: 32054657
[TBL] [Abstract][Full Text] [Related]
7. Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure.
Shen W; Kerr CM; Przychozen B; Mahfouz RZ; LaFramboise T; Nagata Y; Hanna R; Radivoyevitch T; Nazha A; Sekeres MA; Maciejewski JP
Br J Haematol; 2019 Jun; 185(5):935-939. PubMed ID: 30891747
[TBL] [Abstract][Full Text] [Related]
8. Incorporating genetic counseling into the evaluation of pediatric bone marrow failure.
Schneider KW; Suttman A; McKinney C; Giller R; Dollerschell K; Nakano TA
J Genet Couns; 2022 Apr; 31(2):433-446. PubMed ID: 34570941
[TBL] [Abstract][Full Text] [Related]
9. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
10. Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
Przychodzen B; Makishima H; Sekeres MA; Balasubramanian SK; Thota S; Patel BJ; Clemente M; Hirsch C; Dienes B; Maciejewski JP
Oncotarget; 2018 Jan; 9(2):2050-2057. PubMed ID: 29416752
[TBL] [Abstract][Full Text] [Related]
11. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
Alter BP; Best AF
Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
[TBL] [Abstract][Full Text] [Related]
12. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomics.
Fox LC; Wood EM; Ritchie DS; Blombery P
Int J Lab Hematol; 2020 Jun; 42 Suppl 1():82-89. PubMed ID: 32134198
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
16. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of bone marrow failure syndromes guided by machine learning.
Gutierrez-Rodrigues F; Munger E; Ma X; Groarke EM; Tang Y; Patel BA; Catto LFB; Clé DV; Niewisch MR; Alves-Paiva RM; Donaires FS; Pinto AL; Borges G; Santana BA; McReynolds LJ; Giri N; Altintas B; Fan X; Shalhoub R; Siwy CM; Diamond C; Raffo DQ; Craft K; Kajigaya S; Summers RM; Liu P; Cunningham L; Hickstein DD; Dunbar CE; Pasquini R; De Oliveira MM; Velloso EDRP; Alter BP; Savage SA; Bonfim C; Wu CO; Calado RT; Young NS
Blood; 2023 Apr; 141(17):2100-2113. PubMed ID: 36542832
[TBL] [Abstract][Full Text] [Related]
18. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
19. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.
Bluteau O; Sebert M; Leblanc T; Peffault de Latour R; Quentin S; Lainey E; Hernandez L; Dalle JH; Sicre de Fontbrune F; Lengline E; Itzykson R; Clappier E; Boissel N; Vasquez N; Da Costa M; Masliah-Planchon J; Cuccuini W; Raimbault A; De Jaegere L; Adès L; Fenaux P; Maury S; Schmitt C; Muller M; Domenech C; Blin N; Bruno B; Pellier I; Hunault M; Blanche S; Petit A; Leverger G; Michel G; Bertrand Y; Baruchel A; Socié G; Soulier J
Blood; 2018 Feb; 131(7):717-732. PubMed ID: 29146883
[TBL] [Abstract][Full Text] [Related]
20. Germline and somatic RUNX1 variants in a pediatric bone marrow failure cohort.
Yamamori A; Hamada M; Muramatsu H; Wakamatsu M; Hama A; Narita A; Tsumura Y; Yoshida T; Doi T; Terada K; Higa T; Yamamoto N; Miura H; Shiota M; Watanabe K; Yoshida N; Maemura R; Imaya M; Miwata S; Narita K; Kataoka S; Taniguchi R; Suzuki K; Kawashima N; Nishio N; Iwafuchi H; Ito M; Kojima S; Okuno Y; Takahashi Y
Am J Hematol; 2023 May; 98(5):E102-E105. PubMed ID: 36740830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
